That is why Amgen (NASDAQ: AMGN), considered the world’s largest pharmaceutical company, has decided to acquire Onyx Pharmaceuticals (NASDAQ: ONXX) in a $10.4 billion ... but with the upcoming acquisition, Amgen stock has …
Cancer
Onyx Pharmaceuticals announced that it will delay its New Drug Application (NDA) filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Controls (CMC) review division of the U.S. Food and Drug …
Among leading biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG), Onyx Pharmaceuticals (NASDAQ: ONXX) and Vertex Pharmaceuticals ... surveyed by Thomson/First Call, 13 rate the stock at Strong Buy …
In the next few weeks, investors in cancer drug maker Onyx Pharmaceuticals (ONXX) will find out if the company will get a speedy review of its experimental treatment carflizomib for multiple myeloma. Some analysts are skeptical and -- …
In order to become successful, you need to have information as it happens and understand how it plays out into future stock price. This is our expertise ... d=2013-08-20&s=CVX-APA-ONXX-PG Did you want to hear about CVX at $70.06 …
New York, NY Point Roberts, WA - August 26, 2013 (Investorideas.com Newswire) Investorideas.com staff: …
Shares of Amgen (AMGN) and Onyx Pharmaceuticals (ONXX) were both up in the stock market Monday morning after their long-awaited merger was finally announced. Late Sunday, the two biotechs said they'd agreed on a price of $125 a …
Onyx Pharmaceuticals (ONXX) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the …
After closing a recent acquisition, Onyx Pharmaceuticals Inc. (ONXX) is shifting its focus inward as it looks ... Register now to create your own custom streaming stock watchlist. NYSE, AMEX, and ASX quotes are delayed by at least 20 …
Global Geophysical Services Inc. topped the list of Biggest Percentage Price Gainers among common stocks on the New York Stock Exchange at the close. See the full list . Onyx Pharmaceuticals Inc. topped the list of Biggest Percentage …